- 全部删除
- 您的购物车当前为空
β-Glucuronidase-IN-3 (Compound 49) 是一种β-glucuronidase的共价变构抑制剂。它对大肠杆菌 β-葡萄糖醛酸酶 (EcGUS) 显示出强效的抑制能力 (IC50: 12.9 nM)。这种作用是通过可逆共价修饰EcGUS的半胱氨酸残基 (Cys28、Cys443和Cys197) 实现的。β-Glucuronidase-IN-3 可应用于研究肠道微生物相关的疾病,尤其在减轻Irinotecan和非甾体抗炎药 (NSAIDs) 的毒性副作用方面。
β-Glucuronidase-IN-3 (Compound 49) 是一种β-glucuronidase的共价变构抑制剂。它对大肠杆菌 β-葡萄糖醛酸酶 (EcGUS) 显示出强效的抑制能力 (IC50: 12.9 nM)。这种作用是通过可逆共价修饰EcGUS的半胱氨酸残基 (Cys28、Cys443和Cys197) 实现的。β-Glucuronidase-IN-3 可应用于研究肠道微生物相关的疾病,尤其在减轻Irinotecan和非甾体抗炎药 (NSAIDs) 的毒性副作用方面。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | β-Glucuronidase-IN-3 (Compound 49) is a covalent allosteric inhibitor targeting β-glucuronidase. It exhibits potent inhibitory activity against Escherichia coli β-glucuronidase (EcGUS) with an IC50 of 12.9 nM. The compound exerts its inhibitory effect through reversible covalent modification of cysteine residues (Cys28, Cys443, and Cys197) on EcGUS. It is applicable in research on gut microbiota-related diseases, particularly in reducing the toxic side effects of Irinotecan and non-steroidal anti-inflammatory drugs (NSAIDs). |
分子量 | 264.14 |
分子式 | C10H7N3OSe |
CAS No. | 3081681-34-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容